Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 49 No. 1, 2019 - Full Issue Stacked PDF
1
x
$
90.00
Lamotrigine and Stevens-Johnson Syndrome Prevention
1
x
$
30.00
Patricia K. Corey-Lisle, PhD, RN,CS-P: Economic Impact of Olanzapine Plus Fluoxetine Combination Therapy Among Patients Treated for Depression: A Pilot Study
1
x
$
30.00
VOL 4 No. 2 Full Issue - February 2002
1
x
$
20.00
VOL 3 No. 1 Full Issue - January 2001
1
x
$
20.00
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
1
x
$
30.00
View Cart
Checkout
Home
Zastrozhin
“Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
The Influence of Concentration of Micro-RNA hsa-miR-370-3p and CYP2D6*4 on Equilibrium Concentration of Mirtazapine in Patients With Major Depressive Disorder
$
30.00
Add to cart
Details
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
